tbuckley/cabot-search huggingface dataset:
The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy
Authors: Yun He, Haixia Fu, Xiaolu Zhu, Qiusha Huang, Qi Chen, Jin Wu, Yuxiu Chen, Peng Zhao, Kai-Yan Liu, Xiaohui Zhang
Journal: Blood (2023)
Description of Patients with HIV and Multicentric Castleman's Disease at the National Institute of Cancerology- Mexico: A 9-Year Experience
Authors: Andres Yesid Yesid Bonilla Salcedo, Mistral Castellanos Mares, Karen Pellon Tellez, Silvia Rivas-Vera, Gerardo A Santana Sierra, Luis Felipe Rubalcava, Cynthia A Marin Romero, Linda M Zapata Cerecedo, Adriana J Resendiz Reyes, Brenda Lizeth Acosta Maldonado
Journal: Blood (2023)
Analysis of the Impact of Body Mass Index (BMI) on the Durability of Response in Patients with Aplastic Anemia Treated with Weight-Adjusted Horse Anti-Thymocyte Globulin (hATG)
Authors: Jeanette Walter, Benjamin Rolles, Yannic Schumacher, Frauke Theis, Leo Hansmann, Daniel Heudobler, Markus Radsak, Michael Heuser, Julia-Annabell Georgi, Jörg Chromik, Beatrice Drexler, Jörg Schubert, Kim Kricheldorf, Susanne Isfort, Jens Panse, Tim H. Brümmendorf, Fabian Beier
Journal: Blood (2023)
PRT2527, a Novel Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, Has Potent Antitumor Activity in Combination with BTK and BCL2 Inhibition in Various Lymphoid Malignancies
Authors: Norman Fultang, Ashley M Schwab, Sophia McAneny-Droz, Diane Heiser, Peggy A Scherle, Neha Bhagwat
Journal: Blood (2023)
Real-Life Data of Cyclosporine (CsA) Tapering in Patients with Very/ Severe Aplastic Anemia (v/sAA) Treated with Horse Anti-Thymocyte Globulin (hATG/CsA) Suggest Higher Risk of AA Relapse at Cyclosporine Plasma Levels below 100 Nanogram per Milliliter
Authors: Jeanette Walter, Kim Kricheldorf, Yannic Schumacher, Susanne Isfort, Jörg Chromik, Beatrice Drexler, Frauke Theis, Jens Panse, Tim H. Brümmendorf, Fabian Beier
Journal: Blood (2023)
Genome-Wide CRISPR Screen Identifies ZNF451 Regulating Sensitivity to Topoisomerase 2 Inhibitors in Peripheral T-Cell Lymphoma Cells
Authors: Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa
Journal: Blood (2023)
Identifying Causes of Unscheduled Healthcare Interactions and Changes to Patient Disposition in Individuals Receiving Outpatient Commercial Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Anna J Howard, Tala Shekarkhand, Issam S. Hamadeh, Alice Wang, Dhwani Patel, Carlyn Tan, Malin Hultcrantz, Sham Mailankody, Hani Hassoun, Urvi A Shah, Neha Korde, Kylee H Maclachlan, Heather Landau, Michael Scordo, Gunjan L. Shah, Oscar Boutros Lahoud, Sergio A. Giralt, David Chung, Alexander Lesokhin, Saad Z Usmani, Ross Firestone
Journal: Blood (2023)
The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Authors: Jianai Sun, Yi Xu, Yuanfei Shi, Jinghan Wang, Xueying Li, Xiaolong Zheng, Wen-Juan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood (2023)
Prevalence of Cannabis Use Disorder and Its Association with Major Adverse Cardiac Events in Patients with Sickle Cell Crisis: Insights from the National Inpatient Sample
Authors: Pratiksha Shankarlal Nathani, Maithri Vallabhaneni, Kanishka Uttam Chandani, Kalaivani Babu, Ummul Asfeen, Beenish Najam, Srinishant Rajarajan, Sai Gautham Kanagala, Zainab Muslehuddin, Shubham Adroja, Akhil Jain, Rupak Desai
Journal: Blood (2023)
The Unique BCR Inhibiting Properties of BMS-986205 in Chronic Lymphocytic Cells
Authors: Claudio Giacinto Atene, Stefania Fiorcari, Nicolò Mesini, Rossana Maffei, Silvia Martinelli, Flora Pilato, Monica Maccaferri, Leonardo Potenza, Mario Luppi, Roberto Marasca
Journal: Blood (2023)
Association between Heavy Metal Exposure and Idiopathic Aplastic Anemia in Adolescents and Adults:a Case Control Study from Northern India
Authors: Arihant Jain, Sarthak Wadhera, Pankaj Malhotra, Charanpreet Singh, Deepesh Pravinkumar Lad, Alka Rani Khadwal, Gaurav Prakash, Neelam Varma, Prabhakar Reddy
Journal: Blood (2023)
ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial
Authors: Sarah Nikiforow, Mitchell Horwitz, John M. McCarty, Anum Abbas, James M. Coghill, Jenny Stanton, Julie Ma, Spyridoula Vasileiou, Sarah Gilmore, Bhagirathbhai Dholaria, Rabi Hanna, Randy Taplitz, Rajat Bansal
Journal: Blood (2023)
Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia
Authors: Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Huang Li, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hongyan Tong, Jie Jin, Huafeng Wang
Journal: Blood (2023)
Detection of Cryptic Gene Fusion and Chimeric RNA Variants in Relapsed/Refractory Acute Myeloid Leukemia Patients Diagnosed with KMT2A/Afdn Chromosomal Translocation
Authors: Esther G Chong, Bowon Joung, Durga Cherukuri, Yan Liu, Saied Mirshahidi, Jane Xu, Jeffery Xiao, Xi Huang, Cristina Maria Ghiuzeli, David Baylink, Qian Liu, Xuelian Chen, Homa Dadrastoussi, Julian Olea, Kaijin Wu, Kevin R. Kelly, Xi Zhang, Fengzhu Sun, Mojtaba Akhtari, Huynh Cao, Yi Xu
Journal: Blood (2023)
The Impact of Adding Rituximab to the Standard Chemotherapy + TKI Regimen in Adults with Philadelphia-Positive B Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Authors: Sergio Rodriguez-Rodriguez, Fausto Alfredo Rios Olais, Analy Mora, Christian Omar Ramos Peñafiel, Victor Itaí Urbalejo Ceniceros, Yadith Karina Lopez-Garcia, Andres Gomez-De Leon, Nancy Delgado-López, Mistral Castellanos Mares, Patricia Carolina Figueroa Hernandez, Roberta Demichelis
Journal: Blood (2023)
Survival Impact of the Second Malignancies Among the Lymphoid Neoplasm
Authors: Tong-Yoon Kim, Seok-Goo Cho, Youngwoo Jeon, Gi-June Min, Ki-Seong Eom, Sung-Soo Park, Jae-Ho Yoon, Byung-Sik Cho, Silvia Park, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Heeje Kim, Jong-Wook Lee
Journal: Blood (2023)
Clinical Characterization of Fusion Genes in Acute Myeloid Leukemia without Recurrent Genetic Abnormalities
Authors: Francesca Guijarro, Marc Dabad, Mònica López-Guerra, Alex Bataller Torralba, Sandra Castaño-Díez, Carlos Jimenez-Vicente, Marta Garrote, José Ramón Álamo Moreno, Marta Pratcorona, Neus Villamor, Dolors Colomer, Silvia Bea, Dolors Costa, Anna Esteve-Codina, Marina Díaz-Beyá, Jordi Esteve
Journal: Blood (2023)
Does Socioeconomic Status Have an Impact on Light Chain (AL) Amyloidosis Disease Characteristics and Outcomes?
Authors: Mingqian Lin, Aniko Szabo, Liliana Pezzin, Jing Dong, Binod Dhakal, Meera Mohan, Ravi Narra, Marcelo Pasquini, Anita D'Souza
Journal: Blood (2023)
Detection of <i>KMT2A</i> Partial Tandem Duplications ( <i>KMT2A</i>-PTDs) in Healthy Donors Using Next Generation Sequencing
Authors: Jiajie Huang, Haigang Gu, Janet Orton, Marina Sedova, Amir Marcovitz, Jennifer Burke, Sarah Brozio, Paul Williams, Scott Myrand, Nate Olowo, Adam Broomer, Brendan Deal, Collyn Seeger, Seth Sadis, Sophie Rozenzhak, Fiona Hyland, Guang Liu
Journal: Blood (2023)
Survival Outcome of Autologous or Allogeneic Stem Cell Transplantation in 49 Patients with Extranodal NK/T-Cell Lymphoma
Authors: Mao Jin, Sicheng Ai, Tao You, Xiao Ma, Feng Chen, Caixia Li, Zhengming Jin, Depei Wu, Haiwen Huang
Journal: Blood (2023)
Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Authors: Suning Chen, Yanli Zhang, Na Xu, Hui Sun, Li Weiming, Yunfan Yang, Zunmin Zhu, Minghui Duan, Sixuan Qian, Yu Zhu, Jianmin Luo, Xiaodong Wang, Wei Yang, Weiying Gu, Fei Li, Bingcheng Liu, Yunxiao Xu, Zhenfang Liu, Chunling Wang, Yirong Jiang, Li Meng, Qin Wen, Yanli Xu, Xingli Zou, Wei Wang, Yan Xue, Hao Xu, Kehong Bi, Fuling Zhou, Liangming Ma, Rong Fu, Guifang Ouyang, Kaiyang Ding, Depei Wu
Journal: Blood (2023)
Efficacy and Safety of Modified BV-AVD-R Regimen in Chinese Children with Previously Untreated Intermediate- and High-Risk Classical Hodgkin's Lymphoma: An Open Label, Non-Randomized, Single-Arm, Phase 2 Study from Single Center
Authors: Li Ying, Nan Li, Shuang Huang, Ling Jin, Jing Yang, Chunju Zhou, Xiaoling Wang, Yanlong Duan
Journal: Blood (2023)
RSV Pneumonia Mortality: Hematological Malignancies As a Silent Amplifier - Insights from the National Inpatient Sample 2020
Authors: Zubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, Austin Auyeung, Muhammad Junaid Tariq, Muhammad Jahanzeb Khalil, Farhan Khalid, Christopher Bray
Journal: Blood (2023)
The Reversible BTK Inhibitor Nemtabrutinib Demonstrates Favorable Antitumor Efficacy and Enhances the Function of CAR T Cells in Mantle Cell Lymphoma
Authors: Margaret Elizabeth Simmons, Joseph McIntosh, Tianci Zhang, Yijing Li, Fangfang Yan, Yixin Yao, Lei Nie, Heng-Huan Lee, Wei Wang, Vivian Changying Jiang, Michael Wang, Yang Liu
Journal: Blood (2023)
Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to Treat Analysis
Authors: Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Gonzalo Del Campo Balguerías, Marta Español-Rego, Sergio Navarro, Helena Brillembourg, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Juan Gonzalo Correa, Andrea Rivero, Pablo Mozas, Aina Oliver-Caldes, Eva Gine, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Mercedes Montoro-Lorite, Pilar Ayora, Carlos Fernández de Larrea, Mariona Pascal, Jordi Esteve Reyner, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Journal: Blood (2023)
Efficacy of Protac-Based EZH2 Degrader MS1943 in Lymphoid Malignancies: A Comprehensive Study on the Combined Effects of MS1943 and Ibrutinib
Authors: Youngwoo Jeon, Yurim Jeong, Minseo Yu, Ra Eun Kim, Yoon Seok Choi, Jung-Yeon Lim
Journal: Blood (2023)
Improving Clinical Outcomes in APL: Weight Maintenance Strategies to Reduce Complications during Induction Therapy
Authors: Shreya Desai, Anvay Shah, Michael Stokes, Danielle Bradshaw, Mohammad Mian, Ayushi Chauhan, Amany R. Keruakous, Locke Johnson Bryan, Jorge Cortes, Vamsi K. Kota, Anand Jillella
Journal: Blood (2023)
Establishing Standard of Care in Predicting Serious Complications for Patients Planned to Undergo Allogenic Hematopeotic Stem Cell Transplantation
Authors: Madlen Reschke, Jonathan P. Gross, Janina Hegner, Jonas Seiler, Gülüstan Sürücü, Olaf Penack, Daniel Weschke, David Higgins, Lena Oevermann
Journal: Blood (2023)
Atrial Fibrillation in Patients with Myelofibrosis
Authors: Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Morić Perić, Ivan Zekanović, Rajko Kusec
Journal: Blood (2023)
Characterizing <i>ATM</i> Aberrations in Chronic Lymphocytic Leukemia (CLL): Prognostic Implications and Sensitivity to PARP Inhibition
Authors: Kiyomi Mashima, Mariia Mikhaleva, Stacey M Fernandes, Samantha J. Shupe, Svitlana Tyekucheva, Matthew S. Davids, Jennifer R. Brown
Journal: Blood (2023)
Non-Genotoxic Conditioning for Hematopoietic Stem Cell Transplant through Engineered Stem Cell Antibody Paired Evasion (ESCAPE)
Authors: Nandini Mondal, Alexander Harmon, Elizabeth Budak, Kathy Zhang, Jeffrey Wong, Archita Venugopal Menon, Adam Wolin, Moriah White, Faith Musenge, Adam Camblin, Brent Coisman, Corrina Lucini, Tao Bai, Kangjian Qiao, Wayne Austin, Michelle DeLelys, Hugh Kromer, Lisa Hardy, Megan Law, Raffi Manoukian, Rachel Goldsmith, Kiera Fallon, Mudra Patel, Antoinette Cozier, Colin Lazzara, Jeremy Decker, Rebecca Jenkins, Tanggis Bohnuud, Patricia Feliciano, Seung-Joo Lee, Paul Kopesky, Sarah Smith, Charlotte McDonagh, Nicole Gaudelli, S. Haihua Chu, Adam Hartigan, Gopi Shankar, Giuseppe Ciaramella
Journal: Blood (2023)
Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma
Authors: Shuang Zhao, Jiuyang Zhang, Zheng Yan, Yuanlin Xu, Zhihua Yao, Junfeng Chu, Shuna Yao, Haiying Wang, Wenping Zhou, Xufeng Luo, Peipei Zhang, Yanyan Liu
Journal: Blood (2023)
Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study
Authors: Laurence Legros, Francoise Huguet, Pascale Cony-Makhoul, Irit Touitou, Franck E. Nicolini, Delphine Rea, Marc G. Berger, Madalina Uzunov, Lydia Roy, Martine Escoffre Barbe, Agnes Guerci Bresler, Gabriel Etienne, Elisabeth Daguenet, Amelie Penot, Martine Gardembas Pain, Shanti Ame, Eric Jourdan, Hyacinthe A. Johnson-Ansah, Valerie Coiteux, Antoine Machet, Eric Lippert, Anne Vekoff, Jean Michel Karsenti, Stéphane Morisset, Francois Mahon
Journal: Blood (2023)
Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center &amp; Registry Operations
Authors: Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean M. Devlin, Melissa Nhaissi, Candice Rapoport, Stephanie Chinapen, Amanda Kelly, Deborah Wells, Andromachi Scaradavou, Boglarka Gyurkocza, Esperanza B. Papadopoulos, Ioannis Politikos, Brian C. Shaffer, Juliet N Barker
Journal: Blood (2023)
Cost per Responder Analysis of Patients with Lenalidomide-Refractory Multiple Myeloma Who Received Cilta-Cel from the Cartitude-4 Trial
Authors: Doris K. Hansen, Xiaoxiao Lu, Omar Castaneda, Sonja Sorensen, Saad Z Usmani, Eileen Zhang, Stephen Huo, Sundar Jagannath
Journal: Blood (2023)
Efficacy of Sutimlimab in Improving FACIT-Fatigue Scores in Patients with Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cadenza (Part A) Study
Authors: Alexander Roeth, Ilene Weitz, Yasutaka Ueda, Sylvie Bozzi, Reena Patel, Alia Karaouni, Ronnie Yoo, David Cella, Jennifer Wang
Journal: Blood (2023)
CLL Cells within the Proliferation Centers of the Patient Lymph Nodes Are Enriched for Notch Signaling, Thus NOTCH a Viable Target for CLL Therapy
Authors: Shantaram S. Joshi, Matt Kilng, Furqan Mehdi, Mamta Shukla, Ashima Bhakri, Vipul Shukla, Nagendra K. Chaturvedi, Hamid Band, Javeed Iqbal
Journal: Blood (2023)
Survival of Hodgkin Lymphoma Patients Treated with Novel Immunotherapies after Autologous Stem Cell Transplantation Failure: A Retrospective Analysis of the Italian Lymphoma Foundation (FIL)
Authors: Maura Nicolosi, Valentina Bozzoli, Sabino Ciavarella, Cattina Federica, Gloria Margiotta Casaluci, Ombretta Annibali, Alessia Castellino, Francesco Rotondo, Luigi Petrucci, Federica Cocito, Sofya Kovalchuk, Erika Meli, Natalia Cenfra, Sara Bigliardi, Angelo Fama, Stefano Volpetti, Barbara Botto, Benedetto Bruno, Francesco Zaja
Journal: Blood (2023)
Targeting Mutant KRAS with Novel Mutant-Specific Pharmacological Inhibitors: Activity Against Myeloma and Other Lymphoid Malignant Cells and Molecular Mechanisms of Resistance
Authors: Torsten Steinbrunn, Ryosuke Shirasaki, Olga Dashevsky, Huihui Tang, Shizuka Yamano, Rin Mizuno, Takeru Sugihara, Phaik Ju Teoh, Lisa B Leypoldt, Mariko Kaji, Jeffrey Sorrell, Brian J Glassner, Ricardo De Matos Simoes, James Christensen, Constantine S Mitsiades
Journal: Blood (2023)
High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021
Authors: Benjamin Chin-Yee, Tiancheng Hu, Clarissa Skorupski, Sarah Ghnaim, Bishal Gyawali, Turab Mohammed, James Yu, Gary H. Lyman, Michelle Sholzberg, Lisa Hicks, Nicole M. Kuderer
Journal: Blood (2023)
Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Prospective Phase II Trial in China
Authors: Chongling Hu, Tao Yang, Li Jun, Wenjun Zhang, Bingling Guo, Chaoyu Wang, Jun Liu, Chunyan Xiao, Dehong Huang, Zailin Yang, Tingting Liu, Jieping Li, Yingyu Nan, Yao Liu
Journal: Blood (2023)
Bendamustine Lymphodepletion (LD) Prior to Idecabtagene Vicleucel (Ide-cel) Is Associated with Inferior Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)
Authors: Gayathri Ravi, Susan Bal, Kelly Godby, Smith Giri, Courtney Hebert, Binita Parekh, JoAnn Steele, Jessica Brown, Kathy Langley, Luciano Costa
Journal: Blood (2023)
Outcomes of Lymphoma and Multiple Myeloma Patients Following Inpatient Antineoplastic Treatment
Authors: Mikhaila Rice, Joslyn Rudoni, Marissa Duco, Sharon Zhong, Lauren Burton, Sarah Crisp, Jason Valent, Christy J. Samaras, Louis S. Williams, Jack Khouri, Shahzad Raza, Brian T. Hill, Allison Winter, Robert M. Dean, Paolo F. Caimi, Brad Pohlman, Alexander Heinly, Samantha Kroger, Elizabeth Rosic, Katie Donnelly, Tiffany Carr, Mallory Harder, Faiz Anwer, Deepa Jagadeesh
Journal: Blood (2023)
Building Adaptive Coping and Knowledge to Improve Daily Life (Back2Life): A Pilot Feasibility Trial for Youth with Chronic Sickle Cell Pain
Authors: Soumitri Sil, Nwanna Ifendu, Jan Mooney, Caitlin Shneider, Erin Kelling, Lauren Quast, Delilah Ellzey, Alison Manikowski, Mallory Schneider Hughes, Carlton Dampier, Lindsey L Cohen
Journal: Blood (2023)
Evaluation of the Impact of Tocilizumab Use in Recipients of CAR T Cells for Non-Hodgkin Lymphoma
Authors: Giulio Cassanello, Efrat Luttwak, Sean M. Devlin, Alejandro Luna De Abia, Magdalena Corona, Ivan Landego, Allison Parascondola, Amethyst Saldia, Ana Alarcon Tomas, Parastoo B. Dahi, Richard J. Lin, M. Lia Palomba, Jae H. Park, Gilles Salles, Miguel-Angel Perales, Michael Scordo, Roni Shouval, Gunjan L. Shah
Journal: Blood (2023)
Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program
Authors: Mitchell Horwitz, Stephanie B. Tsai, Andrew R. Rezvani, Richard T Maziarz, Uri Goshen, Stuart Levy, Aurelie Schwarzbach, Roei D. Mazor, Patrick J. Stiff, Gary J. Schiller
Journal: Blood (2023)
Permissive Cardiotoxicity As a Guiding Principle to CAR-T Therapy with Reduced Ejection Fraction Heart Failure
Authors: Forat Lutfi, Briha Ansari, Afraah Hawa, Al-Ola Abdallah, Zubair Shah, Andre Khazak, Hussam Hawamdeh, Marc S. Hoffmann, Muhammad Umair Mushtaq, William Wesson, Aliya Rashid, Maggie Nelson, Leyla Shune, Sunil Abhyankar, Joseph P McGuirk, Charles Porter, Nausheen Ahmed
Journal: Blood (2023)
Parallel Monitoring of Measurable Residual Disease and Chimerism By NGS in Myelodysplastic Syndrome after Allogenic STEM Cell Transplant
Authors: Irene Zamanillo, Santiago Barrio, Alejandro Martín-Muñoz, Sara Dorado, Ana K Ballesteros, Yanira Ruiz-Heredia, Margarita Rodriguez, Carolina Martinez-Laperche, Sandra Martín, Blanca Ferrer Lores, Ivan Martin Castillo, Inmaculada Rapado, Rosa Ayala, Joaquin Martinez-Lopez, Maria Teresa Cedena Romero
Journal: Blood (2023)
Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report
Authors: Gioia De Angelis, Alessia Fiorini, Giulio Trapè, Valentina Panichi, Maria Gabriela Chavez, Elisa Emanueli Cippitelli, Vincenza Innocenti, Roberta Perazzini, Roberta Talucci, Giuseppe Topini, Ambra Di Veroli, Caterina Mercanti, Fiammetta Natalino, Michela Tarnani, Marco Morucci, Cristina Mastini, Assunta Silvestri, Alessandro Andriani, Marco Montanaro, Silvia Ciambella, Roberto Latagliata
Journal: Blood (2023)
Academic Outreach and Collaboration with Community Oncology Practices to Enhance Referrals and Reduce Disparities in Hematological Malignancies
Authors: Vamsi K. Kota, Danielle Bradshaw, Dheeraja Kota, Mohammad Mian, Sarah Jimenez, Courtney Corley, Rachel Ashley, Irina Shishkina, Joy Brown, Gita Giddens, Kimberly Green, Amany R. Keruakous, Ayushi Chauhan, Locke Johnson Bryan, Jorge Cortes, Anand Jillella
Journal: Blood (2023)
Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World
Authors: Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang
Journal: Blood (2023)
Dose Escalation of Blinatumomab Is a Better Option for MRD-Positive CR Patients, Results from a Single-Center Real World Study of Blinatumomab for B-Cell Acute Lymphoblastic Leukemia in China
Authors: Sijie Tang, Jiayi Ren, Weiyang Liu, Xiangqin Weng, Yongmei Zhu, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood (2023)
Retrospective and Observational Study on CAR-T 19 Bridge Therapies in Pediatric, Adolescents and Young Adults &amp;lt;24 Years with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Experience of the Spanish Hematopoietic Stem Cell Trasplantation and Cellular Therapy Group (GETH-TC)
Authors: Víctor Galán-Gómez, Berta González-Martínez, Anna Alonso-Saladrigues, Susana Rives, Agueda Molinos Quintana, Jose Antonio Perez Simon, Blanca Herrero-Velasco, Mi Kwon, Pere Barba, Mario Sánchez-Salinas, Lucía López-Corral, Anna Torrent, Rafael Hernani, Odelaisy Leon Triana, Antonio Pérez-Martínez
Journal: Blood (2023)
Rituximab Improves Clinical Outcomes of CAR-T Therapy for r/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion
Authors: Yangzi Li, Sining Liu, Qingya Cui, Lingling Liu, Zheng Li, Wei Cui, Mengyun Li, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood (2023)
The Clinical Outcome of Patients with Refractory/Relapsed Lymphoid Blastic Phase of Chronic Myeloid Leukemia Treated with CAR T-Cells Therapy
Authors: Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Tianhui Liu, Lijuan Qi, Jia Chen, Lei Yu, Depei Wu, Xu Yang
Journal: Blood (2023)
Health Care Resource Utilization (HCRU) and Cost of Management of Cytokine Release Syndrome (CRS) and Neurological Events (NEs) in Patients with R/R CLL/SLL Receiving Lisocabtagene Maraleucel (liso-cel) Treatment in the TRANSCEND CLL 004 Study
Authors: Farrukh T. Awan, November McGarvey, Abraham Lee, Ken Imanak, Simran K. Tiwana, Sean Garrison, Masoom Priyadarshini
Journal: Blood (2023)
Global Distribution of Clinical Trials on Chimeric Antigen Receptor T-Cells in the Pediatric Population: The Economic Impact on Clinical Trials Development
Authors: David A. Martinez, Fabio Samir Vargas Cely, Rhea Hans, Eider Moreno-Cortes, Juan Esteban Garcia-Robledo, Pedro Franco-Fuquen, Daniela Alejandra Castro, Januario E. Castro
Journal: Blood (2023)
First Fever between Lymphodepletion and Day 30 after CAR-T Cell Therapy: Patterns, Origins, and Implications in Lymphoma Patients
Authors: Giovanna Melica, Alejandro Luna, Teng Fei, Magdalena Corona, Parastoo Bahrami Dahi, Joshua Fein, Sergio A. Giralt, Sandeep Raj, Ivan Landego, Richard J. Lin, Maria Lia Palomba, Allison Parascondola, Jae H. Park, Gilles Salles, Susan K. Seo, Amethyst Saldia, Michael Scordo, Ana Alarcon Tomas, Gunjan L. Shah, Miguel-Angel Perales, Ying Taur, Roni Shouval
Journal: Blood (2023)
Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database
Authors: Frank Snopek, Ali Seddighzadeh, Megan Flynn, Ling-Yu Cai, Esther Chen, Weichung Joe Shih, Albert Qin, Raymond W Urbanski
Journal: Blood (2023)
Early Autologous Hematopoietic Stem Cells (AHSC) Boost (HCB) to Overcome Immune Effector Cell-Associated Hematotoxicity (ICAHT) after CAR T-Cell Therapy for Lymphoma: A Single Center Experience
Authors: Safia Yousfi, Blandine Guffroy, Celestine Simand, Karin Bilger, Elise Toussaint, Mathieu Baldacini, Luc Matthieu Fornecker, Bruno Lioure
Journal: Blood (2023)
Platinum Talen-Mediated Knock-in of Single-Stranded DNA Templates Facilitates Manufacturing of Clinical-Scale Non-Virally Gene-Edited T Cells from Peripheral Blood
Authors: Kayo Toishigawa, Taro Edahiro, Kenta Magoori, Hiroyuki Sato, Saori Fukunaga, Yemima Suryani Budirahardja, Hiroshi Ureshino, Ryuji Suzuki, Tetsushi Sakuma, Takashi Yamamoto, Tatsuo Ichinohe
Journal: Blood (2023)